Commit To Buy Cytokinetics At $45, Earn 28.7% Annualized Using Options
Investors considering a purchase of Cytokinetics Inc (Symbol: CYTK) shares, but tentative about paying the going market price of $54.22/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particu
:max_bytes(150000):strip_icc():format(jpeg)/PropertyValuation-4ecdfe3a87144fe998087ef433f49c13.jpeg "Is There a Gender Gap in Home Equity Loans?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1346781100-2724c28da6b2479b88db9d1337ebe926.jpg "Buy Now, Pay Later or Rent-to-Own: Which Is the Smarter Way to Pay for Purchases?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1917868586-d64880817bca4098bc8be36bbd17a4e9.jpg "Should You Trade Options on Spot Bitcoin ETFs?")